SPRAVATO spray nasal 28 mg fl
7680671030013
CH-67103
N06AX27
01.06.0.
Reimbursement limitations:
SPRAVATO
SPRAVATO est remboursé, après garantie de prise en charge par l'assureur-maladie et après consultation préalable …
1 / 2
google
Details
- Product number
- 6710301
- CPT
- -
- Packaging group
- 1
- Unit
- Nasenspray, Lösung à 28 mg (2 Sprühstösse)
- Composition
- esketaminum 28 mg ut esketamini hydrochloridum, acidum citricum monohydricum, dinatrii edetas, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 0.2 ml.
Articles (1)
Spravato, Nasenspray, Lösung
Nasenspray
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
28.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 201.15
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/10/2022
Authorization holder
Janssen-Cilag AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 67103
- Drug name
- Spravato, Nasenspray, Lösung
- Galenic form
- NASS
- ATC Code
- N06AX27
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 25/02/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 01.06.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SPRAVATO spray nasal 28 mg fl
- Description (DE)
- SPRAVATO Nasenspray 28 mg Fl
- Market launch
- 25/02/2020
- Narcotic (BTM)
- No